Skip to main content
logo
Abrdn Life Sciences Investors logo
Abrdn Life Sciences Investors (HQL)
NYSE: HQL · Real-Time Price · USD
18.15
+0.72 (4.13%)
Oct 9, 2026, 4:00 PM EDT - Market closed

HQL Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Capitalization
552448412327343505
Market Cap Growth
-8.58%26.18%-4.83%-31.99%22.27%
Enterprise Value
551448412336352505
Last Close Price
18.1513.7111.668.558.5511.91

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PE Ratio
2.795.234.8414.62-7.83
PS Ratio
497.32231.02103.6393.42113.77220.89
PB Ratio
0.980.870.900.810.860.97
P/TBV Ratio
0.980.870.900.810.860.97
P/OCF Ratio
13.8614.12----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
EV/Sales Ratio
496.55231.02103.6396.09116.55220.89

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Debt / Equity Ratio
----0.030.02
Net Debt / Equity Ratio
-0000.030.02
Asset Turnover
0.000.000.010.010.010.00
Quick Ratio
1.550.710.277.570.040.01
Current Ratio
1.610.730.3230.460.700.80
Return on Equity (ROE)
41.42%17.59%19.80%5.59%-22.71%12.82%
Return on Assets (ROA)
-0.61%-0.43%-0.28%-0.33%-0.39%-0.51%
Return on Capital Employed (ROCE)
-0.80%-0.70%-0.40%-0.50%-0.80%-0.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Earnings Yield
35.91%19.11%20.68%6.84%-30.45%12.78%
Dividend Yield
10.03%13.27%14.24%14.96%17.19%14.02%
Payout Ratio
34.37%36.96%----
Buyback Yield / Dilution
-5.32%-5.48%-4.74%-4.33%-4.10%-3.29%
Total Shareholder Return
4.71%7.79%9.50%10.63%13.09%10.73%
SEC Filings: 10-K · 10-Q